Ebola and Marburg hemorrhagic fevers are acute viral diseases that often lead to severe illness and death in humans and other primates. The infections typically affect multiple organs in the body and are often accompanied by hemorrhage (bleeding). Once the virus has been transmitted from an animal host to a human, it can then spread through person-to-person contact.
Researchers in the NIAID Division of Intramural Research and at the Institute’s Vaccine Research Center as well as NIAID-supported scientists in external facilities are studying all aspects of Ebola and Marburg viruses, how they spread, and how they cause disease. Investigators seek better ways to diagnose and treat Ebola and Marburg fevers, including promising work on vaccines.
Media Availability: NIH Experts Offer Lessons Learned from the 2014-2015 Ebola Outbreak—Jan. 14, 2016
Media Availability: Single Dose Ebola Vaccine is Safe and Effective in Monkeys against Outbreak Strain—Aug. 6, 2015
NIH Ebola Study Shows Consistent Immune Inhibition by Historic and Recent Ebola Virus Strains—Aug. 5, 2015
Media Availability: Investigational Aerosolized Ebola Vaccine Shows Promise in Nonhuman Primates—July 13, 2015
All Ebola and Marburg News Releases
Last Updated January 14, 2016